News
Construction on the site will begin in the fall and is expected to be finished by 2027. North Chicago is already home to ...
18h
TipRanks on MSNAbbVie’s ABBV-399 Study: A Potential Game-Changer in Cancer Treatment
Abbvie (($CC:ABBV.CUR)) announced an update on their ongoing clinical study. AbbVie is conducting a Phase 1/1b study titled ‘A ...
AbbVie will invest $195 million in its North Chicago, Illinois, manufacturing plant to expand domestic API production in the ...
18h
TipRanks on MSNAbbVie’s ABBV-319 Study: A Potential Game-Changer in B-cell Malignancies
Abbvie (($CC:ABBV.CUR)) announced an update on their ongoing clinical study. AbbVie is conducting a clinical study titled ‘A ...
The expansion is part of AbbVie’s larger $10 billion commitment to U.S. investment in the face of Trump’s tariff threats.
AbbVie Inc.'s Q2 2025 results showcase Skyrizi & Rinvoq's growth, strong finances, and a promising pipeline. Click for my ...
AbbVie will invest $195M to expand API manufacturing at its North Chicago plant, boosting U.S. pharmaceutical innovation, ...
AbbVie, a global leader in life sciences, announced Tuesday the company’s is investing $195 million to expand its North ...
NORTH CHICAGO Governor JB Pritzker, AbbVie, and the Illinois Department of Commerce and Economic Opportunity (DCEO) today ...
AbbVie said on Thursday its tariff exposure is not expected to exceed that of rivals, and raised its 2025 profit forecast ...
Over the past five years, ABBV has experienced a negative one-day return following its earnings announcements in 65% of ...
Eli Lilly said on Tuesday its drug for a type of blood cancer was more effective in a head-to-head study against AbbVie's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results